ALPS Advisors’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,199
Closed -$531K 1086
2025
Q4
$531K Buy
14,199
+122
+0.9% +$4.01K ﹤0.01% 708
2025
Q3
$388K Buy
14,077
+3,476
+33% +$120K ﹤0.01% 924
2025
Q2
$335K Buy
10,601
+128
+1% +$4.12K ﹤0.01% 896
2025
Q1
$348K Buy
10,473
+1,229
+13% +$44.1K ﹤0.01% 805
2024
Q4
$318K Hold
9,244
﹤0.01% 855
2024
Q3
$370K Sell
9,244
-1,984
-18% -$69.7K ﹤0.01% 744
2024
Q2
$339K Sell
11,228
-59
-0.5% -$1.77K ﹤0.01% 767
2024
Q1
$379K Buy
11,287
+2,895
+34% +$92.9K ﹤0.01% 665
2023
Q4
$271K Sell
8,392
-478
-5% -$13.3K ﹤0.01% 906
2023
Q3
$291K Buy
+8,870
New +$308K ﹤0.01% 893
2023
Q1
Sell
-6,880
Closed -$379K 1074
2022
Q4
$379K Sell
6,880
-27
-0.4% -$1.49K ﹤0.01% 698
2022
Q3
$306K Buy
+6,907
New +$337K ﹤0.01% 751

Other funds holding HRMY